Hospital heart pill may prevent repeat crises
NCT ID NCT04363697
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether starting the drug dapagliflozin during a hospital stay for acute heart failure can reduce the risk of death or worsening heart failure. Over 2,400 adults who were stable after initial treatment were randomly given either dapagliflozin or a placebo. The goal was to see if the drug helps prevent future heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
TIMI Study Group
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a second diuretic boost recovery from heart failure?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?